{"title":"A Drug Pricing \"Transparency\" Bill With Strong Bipartisan Support But Would It Accomplish Much?","authors":"Stephen Barlas","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Several drug-price \"remedy\" bills are floating around Congress, with most being described as a \"first step.\" So why is no one referring to that step as significant?</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 6","pages":"323"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534173/pdf/ptj4406323.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"P and T","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Several drug-price "remedy" bills are floating around Congress, with most being described as a "first step." So why is no one referring to that step as significant?